INVITRO ANTIMICROBIAL SUSCEPTIBILITY OF RECENT CLINICAL ENTERIC ISOLATES TO NEWER ANTIMICROBIAL AGENTS INCLUDING AMPICILLIN SULBACTAM (2/1) AND AMPICILLIN SULBACTAM (1/1)

被引：0
|
作者：
KHARDORI, N [1 ]
WILSON, K [1 ]
RABINOVICH, S [1 ]
机构：
[1] SO ILLINOIS UNIV, SCH MED, SPRINGFIELD, IL 62708 USA
来源：
CLINICAL RESEARCH | 1992年 / 40卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
下载
收藏
页码：A753 / A753
页数：1
相关论文
共 50 条
  • [21] INVITRO SUSCEPTIBILITY OF CAMPYLOBACTER-JEJUNI TO 27 ANTIMICROBIAL AGENTS AND VARIOUS COMBINATIONS OF BETA-LACTAMS WITH CLAVULANIC ACID OR SULBACTAM
    VANDERAUWERA, P
    SCORNEAUX, B
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (01) : 37 - 40
  • [22] SUSCEPTIBILITY OF RECENT CLINICAL ISOLATES TO TEMAFLOXACIN (A-63004) AND OTHER ANTIMICROBIAL AGENTS
    QADRI, SMH
    UENO, Y
    BURNS, JJ
    ALMODOVAR, E
    RABEA, N
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1992, 18 (08) : 311 - 317
  • [23] THE ANTIBACTERIAL ACTIVITY INVITRO OF OFLOXACIN IN COMPARISON WITH OTHER ORALLY-ADMINISTERED ANTIMICROBIAL SUBSTANCES ON AMPICILLIN-RESISTANT CLINICAL ISOLATES
    SEIBERT, G
    KLESEL, N
    LIMBERT, M
    SCHRINNER, E
    WINKLER, I
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1984, 34-2 (11): : 1552 - 1554
  • [24] Modulatory effects of Ampicillin/Sulbactam on glial glutamate transporters and metabotropic glutamate receptor 1 as well as reinstatement to cocaine-seeking behavior
    Hammad, Alaa M.
    Alasmari, Fawaz
    Althobaiti, Yusuf S.
    Sari, Youssef
    BEHAVIOURAL BRAIN RESEARCH, 2017, 332 : 288 - 298
  • [25] Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazonee-sulbactam
    Jean, Shio-Shin
    Liao, Chun-Hsing
    Sheng, Wang-Huei
    Lee, Wen-Sen
    Hsueh, Po-Ren
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2017, 50 (04) : 454 - 463
  • [26] In vitro efficacy of meropenem in combination with colistin, ampicillin-sulbactam against multidrug-resistant blaNDM-1-positive acinetobacter baumannii strains
    Hu, Huizheng
    Liu, Jing
    Su, Gengxun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (12): : 13251 - +
  • [27] USE OF AMPICILLIN-SULBACTAM FOR TREATMENT OF EXPERIMENTAL MENINGITIS CAUSED BY A BETA-LACTAMASE-PRODUCING STRAIN OF ESCHERICHIA-COLI K-1
    GUERRAROMERO, L
    KENNEDY, SL
    FOURNIER, MA
    TUREEN, JH
    TAUBER, MG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (10) : 2037 - 2041
  • [28] Clinical Characteristics of Bloodstream Infections Due to Ampicillin-Sulbactam-Resistant, Non-Extended-Spectrum-β-Lactamase-Producing Escherichia coli and the Role of TEM-1 Hyperproduction
    Waltner-Toews, Rebecca I.
    Paterson, David L.
    Qureshi, Zubair A.
    Sidjabat, Hanna E.
    Adams-Haduch, Jennifer M.
    Shutt, Kathleen A.
    Jones, Mark
    Tian, Guo-Bao
    Pasculle, Anthony W.
    Doi, Yohei
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (02) : 495 - 501
  • [29] BETA-LACTAMASE PRODUCTION IN RECENT CLINICAL ISOLATES OF HAEMOPHILUS-INFLUENZAE AND THEIR SUSCEPTIBILITY TO CEFACLOR AND OTHER ANTIMICROBIAL AGENTS
    QADRI, SMH
    LEE, GC
    ELLIS, ME
    SAUDI MEDICAL JOURNAL, 1993, 14 (01) : 59 - 61
  • [30] EVALUATION OF HAEMOPHILUS TYPE-B SYSTEMIC ISOLATES FOR BETA-LACTAMASE AND NON-BETA-LACTAMASE MEDIATED AMPICILLIN RESISTANCE AND FOR SUSCEPTIBILITY TO OTHER ANTIMICROBIAL AGENTS
    WOOLFREY, BF
    LALLY, RT
    EDERER, MN
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 88 (03) : 361 - 365
12345